Blog
Seven countries, one method: how All.Can National Initiatives turn evidence into change
Each starts from a structured understanding of where the system falls short, and each uses that understanding to reach the people who decide how resources are allocated.
Making the economic case for early cancer care: Mission Early at the World Cancer Congress
Finding cancer early saves lives. Does it also make economic sense? New research commissioned by Mission Early, presented at the 2026 World Cancer Congress in Hong Kong, suggests it does in most cases, under important conditions.
Advocating for People-Centered Flexible Care Pathways at the World Cancer Congress
At the World Cancer Congress 2026, global oncology leaders convened for a Roche-sponsored session titled “From System Strain to System Gain: The Value of Flexible Care Pathways in Cancer Care”. All.Can’s Board President, Professor Christobel Saunders, chaired the panel session which explored how healthcare frameworks can evolve to alleviate capacity pressures and better serve patients.
BeOne Medicines supports shared decision-making in CLL
No patient is exactly like another. If cancer care is to become truly person-centred, our systems, tools and conversations must reflect that reality.
All.Can Spain’s recommendations translate into concrete commitments in the Valencian Community
All.Can Spain brings long-term cancer survivors to Madrid and Valencian Regions at a key moment in their oncology agendas
From our members: UAPO on building trust and partnership in Ebola response
Our member, the Uganda Alliance of Patients’ Organisations (UAPO)—a national umbrella body for patient groups—shared its statement on people-centered Ebola preparedness and response. UAPO’s advocacy extends beyond cancer into broader public health, outbreak readiness, and health security. At its core is a conviction familiar to the All.Can community: people affected by a disease are partners in shaping the response, not just an audience to be informed after decisions are made.
All.Can Belgium launches new White Paper on Clinically Meaningful Endpoints
All.Can International is pleased to share the latest publication from our national initiative, All.Can Belgium. Their new white paper, “Measuring what matters: Towards a shared framework for clinically meaningful endpoints in curative oncology”, addresses a timely and complex question at the heart of modern cancer care: how can we ensure that the endpoints used in clinical trials, access pathways and decision-making truly reflect outcomes that matter to patients, clinicians and society?